![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Production & Manufacturing
Prokarium and Probiomed Scale Up Manufacture of Oral Vaccines
Biotech firms Prokarium and Probiomed have announced a collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability...
Industry Reports
OncoGenex Pharmaceuticals and Achieve Life Science Announce Definitive Merger Agreement
OncoGenex Pharmaceuticals, Inc , a publicly held oncology biopharmaceutical company, and Achieve Life Science, Inc , a privately held specialty pharmaceutical company, announced that...
White Papers
The Future of Digital Health:Technological Advancements That Will Impact The Pharmaceutical Industry
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution. ...
Production & Manufacturing
Synpromics and GE Healthcare to collaborate to Extend the Toolbox for Production of Biologics
Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised...
Packaging & Labelling
Tekni-Films latest flexible packaging materials for medical device packaging Update during MD&M West
The latest in rigid and flexible packaging materials for medical device and pharmaceutical applications will be featured by Tekni-Films, a Tekni-Plex company, at MD&M...
Clinical Trials
Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera for Treatment of Dry EyeÂ
Sun Pharma (SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies), announced successful Phase 3 confirmatory...
Production & Manufacturing
Xenikos awarded EUR 1 million innovation credit extension to support T-Guard(TM) development
Xenikos B.V focused on the development of innovative immunotherapies for the treatment of patients suffering from serious immune diseases or rejection after transplantation, ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read